GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Univo Pharmaceuticals Ltd (XTAE:UNVO-M) » Definitions » YoY EBITDA Growth

Univo Pharmaceuticals (XTAE:UNVO-M) YoY EBITDA Growth : -288.70% (As of Jun. 2022)


View and export this data going back to 2011. Start your Free Trial

What is Univo Pharmaceuticals YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Univo Pharmaceuticals's YoY EBITDA Growth for the quarter that ended in Jun. 2022 was -288.70%.

Univo Pharmaceuticals's EBITDA per Share for the three months ended in Jun. 2022 was ₪-6,593.33.

Univo Pharmaceuticals YoY EBITDA Growth Historical Data

The historical data trend for Univo Pharmaceuticals's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Univo Pharmaceuticals YoY EBITDA Growth Chart

Univo Pharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only - -11,502.46 90.16 110.67 36.38

Univo Pharmaceuticals Quarterly Data
Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -272.96 -759.45 68.63 -288.70

Univo Pharmaceuticals YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Univo Pharmaceuticals's YoY EBITDA Growth for the fiscal year that ended in Dec. 2021 is calculated as:

YoY EBITDA Growth (A: Dec. 2021 )
=(EBITDA per Share (A: Dec. 2021 )-EBITDA per Share (A: Dec. 2020 ))/ | EBITDA per Share (A: Dec. 2020 ) |
=(811-594.667)/ | 594.667 |
=36.38 %

Univo Pharmaceuticals's YoY EBITDA Growth for the quarter that ended in Jun. 2022 is calculated as:

YoY EBITDA Growth (Q: Jun. 2022 )
=(EBITDA per Share (Q: Jun. 2022 )-EBITDA per Share (Q: Jun. 2021 )) / | EBITDA per Share (Q: Jun. 2021 )) |
=(-6593.333-3494)/ | 3494 |
=-288.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Univo Pharmaceuticals YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Univo Pharmaceuticals's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Univo Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Univo Pharmaceuticals Ltd (XTAE:UNVO-M) » Definitions » YoY EBITDA Growth
Comparable Companies
XTAE:XTL XTAE:HDST XTAE:CNMD XTAE:PLNT XTAE:BOLT XTAE:KDST XTAE:MTLF XTAE:CANF XTAE:GFC XTAE:EVGN OCSE:NOVO B ASX:CSL REGN VRTX MRNA XKRX:207940 BNTX HKSE:02269 SGEN SZSE:300122
Traded in Other Exchanges
N/A
Address
Harshar 20, Ashkelon, ISR, 7878329
Website
https://www.univopharma.com
Univo Pharmaceuticals Ltd is engaged in designing & developing drugs for the treatment of brain disorders. The company provides cannabis-based products for distribution and export to the international markets.

Univo Pharmaceuticals Headlines

No Headlines